Cargando…

Prevalence of Mental Disorders in Patients With Chronic Thromboembolic Pulmonary Hypertension

OBJECTIVE: Pulmonary hypertension (PH) is a chronic and progressive pulmonary vascular disease resulting in symptoms such as shortness of breath and fatigue and leading to death from right heart failure if not adequately treated. Chronic thromboembolic pulmonary hypertension (CTEPH) is a subgroup of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dering, Madelaine-Rachel, Lepsy, Nicole, Fuge, Jan, Meltendorf, Tanja, Hoeper, Marius M., Heitland, Ivo, Kamp, Jan C., Park, Da-Hee, Richter, Manuel J., Gall, Henning, Ghofrani, Hossein A., Ellermeier, Dietmar, Kulla, Hans-Dieter, Kahl, Kai G., Olsson, Karen M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925996/ https://www.ncbi.nlm.nih.gov/pubmed/35308878 http://dx.doi.org/10.3389/fpsyt.2022.821466

Ejemplares similares

Childhood Maltreatment, Mental Well-Being, and Healthy Lifestyle in Patients With Chronic Thromboembolic Pulmonary Hypertension
por: Lepsy, Nicole, et al.
Publicado: (2022)

Prevalence of Mental Disorders and Impact on Quality of Life in Patients With Pulmonary Arterial Hypertension
por: Olsson, Karen M., et al.
Publicado: (2021)

Metacognitions in Patients With Frequent Mental Disorders After Diagnosis of Pulmonary Arterial Hypertension
por: Caldarone, Flora, et al.
Publicado: (2022)

Childhood Trauma in Patients With PAH—Prevalence, Impact on QoL, and Mental Health—A Preliminary Report
por: Park, Da-Hee, et al.
Publicado: (2022)

Impact of SARS-CoV-2-Pandemic on Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension
por: Park, Da Hee, et al.
Publicado: (2021)

Health Disparities and Differences in Health-Care-Utilization in Patients With Pulmonary Arterial Hypertension
por: Park, Da-Hee, et al.
Publicado: (2022)

Impact of Pulmonary Arterial Hypertension on Employment, Work Productivity, and Quality of Life - Results of a Cross-Sectional Multi-Center Study
por: Fuge, Jan, et al.
Publicado: (2022)

Validity of echocardiographic tricuspid regurgitation gradient to screen for new definition of pulmonary hypertension
por: Gall, Henning, et al.
Publicado: (2021)

Medical management of chronic thromboembolic pulmonary hypertension
por: Pepke-Zaba, Joanna, et al.
Publicado: (2017)

Metacognitive Therapy for Adjustment Disorder in a Patient With Newly Diagnosed Pulmonary Arterial Hypertension: A Case Report
por: Winter, Lotta, et al.
Publicado: (2020)

An epidemiological analysis of the burden of chronic thromboembolic pulmonary hypertension in the USA, Europe and Japan
por: Gall, Henning, et al.
Publicado: (2017)

Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic disease
por: Wiedenroth, Christoph B., et al.
Publicado: (2017)

CXCL13 in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Olsson, Karen M., et al.
Publicado: (2016)

Oral iron supplementation with ferric maltol in patients with pulmonary hypertension
por: Olsson, Karen M., et al.
Publicado: (2020)

Periprocedural safety and outcome after pump implantation for intravenous treprostinil administration in patients with pulmonary arterial hypertension
por: Kamp, Jan C., et al.
Publicado: (2021)

Inspiratory capacity is not altered in operable chronic thromboembolic pulmonary hypertension
por: Richter, Manuel J., et al.
Publicado: (2017)

Riociguat dose titration in patients with chronic thromboembolic pulmonary hypertension (CTEPH) or pulmonary arterial hypertension (PAH)
por: Ghofrani, Hossein A, et al.
Publicado: (2009)

Incidence and characteristics of chronic thromboembolic pulmonary hypertension in Germany
por: Kramm, Thorsten, et al.
Publicado: (2018)

Capillary pCO(2) helps distinguishing idiopathic pulmonary arterial hypertension from pulmonary hypertension due to heart failure with preserved ejection fraction
por: Olsson, Karen M, et al.
Publicado: (2015)

Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Humbert, Marc, et al.
Publicado: (2019)

Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)
por: Marra, Alberto M., et al.
Publicado: (2018)

Acute hemodynamic effects of adaptive servoventilation in patients with pre-capillary and post-capillary pulmonary hypertension
por: Olsson, Karen M., et al.
Publicado: (2015)

Heart rate response during 6-minute walking testing predicts outcome in operable chronic thromboembolic pulmonary hypertension
por: Richter, Manuel Jonas, et al.
Publicado: (2016)

Hepatorenal dysfunction in patients with chronic thromboembolic pulmonary hypertension
por: Yogeswaran, Athiththan, et al.
Publicado: (2023)

Metacognitive Short-Term Intervention in Patients With Mental Disorders Following Cardiovascular Events
por: Gebhardt, Philippa, et al.
Publicado: (2022)

Thin Air Resulting in High Pressure: Mountain Sickness and Hypoxia-Induced Pulmonary Hypertension
por: Grimminger, Jan, et al.
Publicado: (2017)

Pharmacological therapy for patients with chronic thromboembolic pulmonary hypertension
por: Hoeper, Marius M.
Publicado: (2015)

Secondary Traumatic Stress, Mental State, and Work Ability in Nurses—Results of a Psychological Risk Assessment at a University Hospital
por: Bock, Christian, et al.
Publicado: (2020)

The Clinical Significance of HbA1c in Operable Chronic Thromboembolic Pulmonary Hypertension
por: Richter, Manuel Jonas, et al.
Publicado: (2016)

Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension
por: Kim, Nick H, et al.
Publicado: (2017)

Effects of exercise training on pulmonary hemodynamics, functional capacity and inflammation in pulmonary hypertension
por: Richter, Manuel J., et al.
Publicado: (2017)

C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19
por: Pink, Isabell, et al.
Publicado: (2021)

Advanced risk stratification of intermediate risk group in pulmonary arterial hypertension
por: Yogeswaran, Athiththan, et al.
Publicado: (2020)

Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute study
por: Richter, Manuel J., et al.
Publicado: (2019)

COVID-19 in lung transplant recipients—Risk prediction and outcomes
por: Kamp, Jan C., et al.
Publicado: (2021)

Depiction of mosaic perfusion in chronic thromboembolic pulmonary hypertension (CTEPH) on C-arm computed tomography compared to computed tomography pulmonary angiogram (CTPA)
por: Maschke, Sabine K., et al.
Publicado: (2021)

Flow rate variance of a fully implantable pump for the delivery of intravenous treprostinil in pulmonary arterial hypertension
por: Richter, Manuel J., et al.
Publicado: (2020)

Quality of life in patients with chronic thromboembolic pulmonary hypertension
por: Mathai, Stephen C., et al.
Publicado: (2016)

Shifting Instead of Drifting – Improving Attentional Performance by Means of the Attention Training Technique
por: Barth, Vincent, et al.
Publicado: (2019)

Prevalence of Child Maltreatment in Adults With Congenital Heart Disease and Its Relationship With Psychological Well-Being, Health Behavior, and Current Cardiac Function
por: Proskynitopoulos, Phileas J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2cdtqh6t2125mtq6l9jhq237qr